News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
855,212 Results
Type
Article (87044)
Company Profile (704)
Press Release (767451)
Multimedia
Podcasts (154)
Webinars (20)
Section
Business (232902)
Career Advice (4133)
Deals (39771)
Drug Delivery (131)
Drug Development (91146)
Employer Resources (200)
FDA (18214)
Job Trends (17374)
News (397012)
Policy (39855)
Tag
Academia (3002)
Academic (2)
Accelerated approval (15)
Adcomms (33)
Allergies (110)
Alliances (56978)
ALS (123)
Alzheimer's disease (1620)
Antibody-drug conjugate (ADC) (192)
Approvals (18177)
Artificial intelligence (420)
Autoimmune disease (39)
Automation (22)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (139)
Biotechnology (482)
Bladder cancer (109)
Brain cancer (44)
Breast cancer (413)
Cancer (3275)
Cardiovascular disease (263)
Career advice (3542)
Career pathing (34)
CAR-T (217)
CDC (43)
Cell therapy (600)
Cervical cancer (26)
Clinical research (74575)
Collaboration (1174)
Company closure (4)
Compensation (782)
Complete response letters (42)
COVID-19 (2917)
CRISPR (71)
C-suite (410)
Cystic fibrosis (125)
Data (3338)
Decentralized trials (2)
Denatured (55)
Depression (84)
Diabetes (390)
Diagnostics (7009)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (195)
Drug pricing (160)
Drug shortages (36)
Duchenne muscular dystrophy (167)
Earnings (98307)
Editorial (50)
Employer branding (25)
Employer resources (169)
Events (131721)
Executive appointments (931)
FDA (20244)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1052)
Gene editing (154)
Generative AI (42)
Gene therapy (470)
GLP-1 (960)
Government (5302)
Grass and pollen (7)
Guidances (312)
Healthcare (20921)
HIV (47)
Huntington's disease (32)
IgA nephropathy (48)
Immunology and inflammation (198)
Immuno-oncology (15)
Indications (43)
Infectious disease (3124)
Inflammatory bowel disease (168)
Inflation Reduction Act (13)
Influenza (80)
Intellectual property (135)
Interviews (813)
IPO (17909)
IRA (58)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (63)
Layoffs (608)
Leadership (27)
Legal (10139)
Liver cancer (87)
Longevity (12)
Lung cancer (455)
Lymphoma (230)
Machine learning (16)
Management (65)
Manufacturing (495)
MASH (106)
Medical device (14766)
Medtech (14776)
Mergers & acquisitions (22633)
Metabolic disorders (998)
Multiple sclerosis (107)
NASH (23)
Neurodegenerative disease (166)
Neuropsychiatric disorders (48)
Neuroscience (2431)
NextGen: Class of 2025 (7687)
Non-profit (5091)
Now hiring (51)
Obesity (505)
Opinion (296)
Ovarian cancer (108)
Pain (132)
Pancreatic cancer (136)
Parkinson's disease (207)
Partnered (26)
Patents (348)
Patient recruitment (200)
Peanut (55)
People (65851)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23002)
Phase II (32374)
Phase III (24390)
Pipeline (2069)
Policy (260)
Postmarket research (3554)
Preclinical (10393)
Press Release (72)
Prostate cancer (159)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (551)
Real estate (7402)
Recruiting (76)
Regulatory (27390)
Reports (63)
Research institute (2667)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (13)
RSV (62)
Schizophrenia (110)
Series A (175)
Series B (125)
Service/supplier (30)
Sickle cell disease (69)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (38)
Startups (4309)
State (2)
Stomach cancer (17)
Supply chain (86)
Tariffs (75)
The Weekly (97)
Vaccines (954)
Venture capital (62)
Weight loss (345)
Women's health (53)
Worklife (20)
Date
Today (158)
Last 7 days (831)
Last 30 days (2470)
Last 365 days (33811)
2025 (20751)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (73)
Alaska (7)
Arizona (283)
Arkansas (14)
Asia (50635)
Australia (8896)
California (8285)
Canada (2533)
China (760)
Colorado (353)
Connecticut (369)
Delaware (222)
Europe (116247)
Florida (1237)
Georgia (280)
Hawaii (3)
Idaho (67)
Illinois (764)
India (35)
Indiana (406)
Iowa (19)
Japan (250)
Kansas (118)
Kentucky (34)
Louisiana (20)
Maine (74)
Maryland (1162)
Massachusetts (6318)
Michigan (283)
Minnesota (516)
Mississippi (4)
Missouri (109)
Montana (32)
Nebraska (26)
Nevada (89)
New Hampshire (74)
New Jersey (2303)
New Mexico (31)
New York (2285)
North Carolina (1292)
North Dakota (10)
Northern California (3620)
Ohio (265)
Oklahoma (17)
Oregon (48)
Pennsylvania (1765)
Puerto Rico (18)
Rhode Island (41)
South America (1654)
South Carolina (38)
South Dakota (1)
Southern California (3108)
Tennessee (136)
Texas (1266)
United States (31062)
Utah (242)
Virginia (224)
Washington D.C. (80)
Washington State (719)
West Virginia (4)
Wisconsin (89)
There are 855,212 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
GLP-1
A Compounding Problem: How GLP-1s Drove Novo Nordisk’s Rapid Rise and Fall
Novo Nordisk has plummeted back to Earth after a stunning rise driven by Ozempic and Wegovy. Can the storied Danish pharma recover?
August 13, 2025
·
5 min read
·
Nick Paul Taylor
Mergers & acquisitions
Tang Capital’s Concentra on Buyout Binge With Plenty of Biotech Fodder
After a slow 2024, the biotech shell company Concentra Biosciences is back, offering to buy four biotechs in the past month and seven so far this year.
August 13, 2025
·
4 min read
·
Annalee Armstrong
Press Releases
Pharvaris Reports Second Quarter 2025 Financial Results and Provides Business Update
August 12, 2025
·
12 min read
Press Releases
Verrica Pharmaceuticals Reports Second Quarter 2025 Financial Results
August 12, 2025
·
20 min read
Press Releases
Lyra Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 12, 2025
·
13 min read
Press Releases
Fate Therapeutics Reports Second Quarter 2025 Financial Results and Business Updates
August 12, 2025
·
17 min read
Press Releases
Cognition Therapeutics Receives End-of-Phase 2 Meeting Minutes Confirming Alignment with U.S. FDA on Registrational Path for Zervimesine (CT1812) in Alzheimer’s Disease
August 12, 2025
·
8 min read
Press Releases
Lineage Cell Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
August 12, 2025
·
18 min read
Press Releases
Spero Therapeutics Announces Second Quarter 2025 Operating Results and Provides a Business Update
August 12, 2025
·
10 min read
Press Releases
AN2 Therapeutics Reports Second Quarter 2025 Financial Results and Recent Business and Scientific Highlights
August 12, 2025
·
12 min read
1 of 85,522
Next
